China Shineway Pharmaceutical Group Limited

C1S.F·Frankfurt
Compare
0.8000−0.0150 (−1.84%)today
As of Oct 22, 3:25 PM CEST · May be delayed up to 15 min · EUR

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close0.8150
Open0.8050
Day range0.80000.8050
52-week range0.79501.1000
Off day high−0.62%
Off 52-week high−27.27%
Volume1.80K
Avg. volume (3M)0.00
Market cap604.32M
EPS (TTM)0.1300
Forward P/E—
P/E ratio (TTM)6.15
Dividend yield19.15% (0.1600)
Beta (5Y)—
Shares outstanding755.40M
Short interest—
Earnings dateAug 27, 2025 (est.)
Analyst target—
Profit margin—

Against its peers

Compare in full ›
C1S.F 0570.HK 0719.HK 600750.SS 300705.SZ 0455.HK
Market cap 604.32M 5.74B 3.70B 14.45B 5.16B 193.50M
P/E (TTM) 6.2 — 15.2 16.4 13.4 —
Forward P/E — 7.5 17.1 15.2 7.3 —
Price/book 0.6 0.2 0.6 3.6 2.0 0.4
Dividend yield 19.15% — 3.16% 5.97% 3.76% —
1-year change −10.93% −51.66% −26.42% +6.10% −36.87% −33.33%
Today −1.84% −2.15% −2.75% −1.73% −3.10% 0.00%

The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 15 min.

Related companies

Compare ›

What visitors to C1S.F's page also look at.

Company Mkt cap Price Today
Consun Pharmaceutic.Group Ltd.RC1P.F 1.39B 1.6600 −2.92%
361 Degrees International Ltd R36L.F 1.13B 0.5190 −0.76%
Ceryvyn Therapeutics Ltd.UKJ0.F 6.29M 0.0046 0.00%
Zematijos Pienas ABIU8.MU 118.91M 2.8800 0.00%
Daphne International Hldgs LtdRPSX.F 60.34M 0.0305 +1.67%

From the 4Search instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 15 min.

Latest news

All C1S.F news ›

No recent coverage in the 4Search index.

From articles in the 4Search news index.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use.